Quick Answer
GeneDx Holdings Corp. reported Gross Profit of $298.17 million for fiscal year 2025.
GeneDx Holdings Corp. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $298.17M | +53.4% |
| 2024 | $194.40M | +116.0% |
| 2023 | $90.01M | +436.5% |
| 2022 | -$26.75M | -61.1% |
| 2021 | -$16.60M | -512.4% |
| 2020 | $4.03M | -95.1% |
| 2019 | $82.78M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $84.53M | +76.7% | +19.2% |
| June 30, 2025 | $70.90M | +65.1% | +21.2% |
| March 31, 2025 | $58.48M | +56.3% | +22.3% |
| September 30, 2024 | $47.83M | +89.4% | +11.4% |
| June 30, 2024 | $42.95M | +129.0% | +14.8% |
| March 31, 2024 | $37.41M | +145.5% | +48.1% |
| September 30, 2023 | $25.26M | +86.4% | +34.7% |
| June 30, 2023 | $18.76M | +163.4% | +23.1% |
- GeneDx Holdings Corp. showed an increase of +53.4% in Gross Profit compared to the prior fiscal year.
- Over the 2019–2025 period, GeneDx Holdings Corp.’s gross profit has grown by 260.2% (from $82.78 million to $298.17 million).
- The most recent figure is from GeneDx Holdings Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: